Bullish On Halozyme With Short Term Catalysts And Large Buy By A Jazz ... Trefis The second therapy is MabThera SC, or Rituximab, with trade name Rituxan. Rituxan was approved in the US in 1997 for the treatment of non-Hodgkin's lymphoma. With validation of the approval of the monoclonal antibody Herceptin SC, it's looking like ... |
